Literature DB >> 24713417

Clinical impact of sacroplasty on patient mobility.

Jennifer Talmadge1, Kahsi Smith2, Thomas Dykes3, Derek Mittleider3.   

Abstract

PURPOSE: To evaluate the effect of sacroplasty on patient mobility and pain when performed as a treatment for sacral insufficiency fractures.
MATERIALS AND METHODS: Imaging with computed tomography (CT), magnetic resonance imaging, or bone scan confirmed the diagnosis of sacral insufficiency fractures. Baseline clinical mobility scale (CMS) score and visual analog scale (VAS) pain score were recorded. Sacroplasty was performed under CT guidance. Follow-up CMS and VAS scores were assessed at 4, 24, and 48 weeks.
RESULTS: Eighteen elderly patients (age 80 y ± 8.5; 17 women) were treated. Repeated-measures analysis of variance was conducted to assess changes in CMS and VAS scores over time. Pairwise comparisons revealed a significant increase in average CMS score between baseline and all three follow-up points-4 weeks (P < .001), 24 weeks (P < .001), and 48 weeks (P < .001)-indicating improvement in mobility over time. Pairwise comparisons revealed significant differences in mean VAS scores between baseline and all three follow-up time points-4 weeks (P < .001), 24 weeks (P < .001), and 48 weeks (P < .001)-indicating improvement in overall pain level over time.
CONCLUSIONS: Treatment with CT-guided sacroplasty for sacral insufficiency fractures in this elderly population resulted in significant improvement in patient mobility.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24713417     DOI: 10.1016/j.jvir.2014.02.007

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  8 in total

1.  ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation): randomised controlled, feasibility trial in older people.

Authors:  Terence Ong; Ana Suazo Di Paola; Cassandra Brookes; Avril Drummond; Paul Hendrick; Paul Leighton; Matthew Jones; Khalid Salem; Nasir Quraishi; Opinder Sahota
Journal:  BMJ Open       Date:  2022-05-03       Impact factor: 3.006

Review 2.  Safety and efficacy of percutaneous sacroplasty for treatment of sacral insufficiency fractures: a systematic review.

Authors:  Bilal Mahmood; Jordan Pasternack; Afshin Razi; Ahmed Saleh
Journal:  J Spine Surg       Date:  2019-09

Review 3.  Fragility fractures of the sacrum: how to identify and when to treat surgically?

Authors:  D Wagner; C Ossendorf; D Gruszka; A Hofmann; P M Rommens
Journal:  Eur J Trauma Emerg Surg       Date:  2015-04-18       Impact factor: 3.693

4.  Percutaneous Sacroplasty for Painful Sacral Metastases Involving Multiple Sacral Vertebral Bodies: Initial Experience with an Interpedicular Approach.

Authors:  Qing Hua Tian; He Fei Liu; Tao Wang; Ying Sheng Cheng; Chun Gen Wu
Journal:  Korean J Radiol       Date:  2019-06       Impact factor: 3.500

5.  ASSERT (Acute Sacral inSufficiEncy fractuRe augmenTation) randomised controlled, feasibility in older people trial: a study protocol.

Authors:  Dawn van Berkel; Terence Ong; Avril Drummond; Paul Hendrick; Paul Leighton; Matthew Jones; Khalid Salem; Nasir Quraishi; Cassandra Brookes; Ana Suazo Di Paola; Sarah Edwards; Opinder Sahota
Journal:  BMJ Open       Date:  2019-07-10       Impact factor: 2.692

6.  Fluoroscopy-Guided Percutaneous Sacroplasty for Painful Metastases at the Sacral Ala.

Authors:  Qing-Hua Tian; He-Fei Liu; Tao Wang; Chun-Gen Wu; Ying-Sheng Cheng
Journal:  J Pain Res       Date:  2020-01-16       Impact factor: 3.133

7.  'XX'-Sacroplasty: A Novel Technique for Management of "H-Type" Sacral Insufficiency Fractures.

Authors:  Raphael Lotan; Oded Hershkovich; Yigal Bronstein; Joel Finkelstein
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-02-04

8.  Balloon-assisted sacroplasty as a successful procedure for osteoporotic sacral insufficiency fractures after failure of the conservative treatment.

Authors:  D Schwetje; Y El Sayed Hassan Wahd; R Bornemann; T R Jansen; R Pflugmacher; A Kasapovic
Journal:  Sci Rep       Date:  2020-10-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.